Analytical Data
-
Gene name
CYCT
- Application
-
Species
Bovine
-
Source
Yeast
-
Tag
C- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q3SZT9
-
Expression Region
2-105aa
-
Molecular Weight
12.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CYCT, or Cyclin Y, is a member of the cyclin family of proteins that are crucial for cell cycle regulation in eukaryotic organisms. As a regulatory subunit, CYCT participates in the activation of cyclin-dependent kinases (CDKs), which are essential for the progression of the cell cycle and various cellular processes such as transcription and DNA repair. Abnormalities in cyclin function and expression have been linked to various diseases, including cancer, making the study of CYCT and its interactions particularly significant. Recent research has focused on the structural and functional characterization of CYCT, revealing insights into its role in cell cycle control and potential implications for therapeutic interventions. Recombinant CYCT proteins have been produced for these studies, allowing scientists to delve deeper into its biochemical properties and interactions with other proteins. This research not only enhances our understanding of CYCT’s function but also paves the way for developing targeted treatments that can modulate its activity in disease contexts. Through a combination of biochemical assays, structural biology techniques, and cellular models, the ongoing investigations aim to unravel the complexities of CYCT's role in cell proliferation and its potential as a biomarker or therapeutic target in oncology.
